Abstract:Over the last few decades, stem cell-based therapy has become a novel strategy for a variety of disorders including cardiovascular, digestive and respiratory diseases. Among the stem cells investigated, mesenchymal stem cells (MSCs) are the ideal candidate cell source due to their many characteristics, including ease of isolation and expansion, multilineage differentiation potential and immunoregulatory function. Nevertheless MSCs derived from aged donors or patients with agerelated diseases are senescent (Shi et al., 2021). In addition, prolonged in vitro expansion induces MSC senescence (Li et al., 2019). Although allogeneic transplantation of MSCs exerts beneficial effects in the early days post-transplantation, long-term benefits compared with those of autologous MSCs are compromised due to sustained immunorejection (Huang et al., 2010). Senescence severely affects the characteristics and function of MSCs, limiting their application in regenerative medicine. Exploring effective strategies to rejuvenate autologous senescent MSC and improve their therapeutic capacity is vital. Although multiple factors including age, oxidative stress and mitochondrial dysfunction have been reported to mediate MSC senescence, the underlying mechanisms of this senescence remain unclear. There are twelve manuscripts in this Research Topic, highlighting the current understanding of the potential mechanisms underlying MSC senescence and novel strategies to rejuvenate the senescent MSC. Liu et al. and Zhou et al. summarize the current knowledge of phenotypic and biological properties of senescent MSCs and strategies for monitoring and rejuvenation, including gene modification and pretreatment strategies (Liu et al.; Zhou et al.). They also systematically review the molecular mechanisms underlying MSC senescence including epigenetic changes, autophagy, mitochondrial dysfunction and telomere shortening. There is accumulating evidence that autophagy acts as a positive and negative regulator of MSC senescence (Ma et al., 2018; Yang et al., 2018). Rastaldo et al. discuss these conflicting roles of autophagy in MSC senescence and potential mechanistic explanations for such an intricate liaison (Rastaldo et al.). Sirtuin 3 (SIRT3), an NAD + -dependent deacetylase, regulates a variety of physiological and pathological processes including aging and aging-related diseases. Ma et al. have shown that reduced Sirt3 expression contributes to age-related natural senescence and H2O2-induced premature senescence of rat bone marrow (BM)-MSCs by stimulating cellular reactive oxygen species (ROS) production and DNA injury (Ma et al.). Overexpressing Sirt3 partly reversed the senescence-associated phenotypic features of natural and premature senescent MSCs by alleviating ROS generation and upregulating SOD2 expression. Qin et al. reveal that knockout of NO synthase 2 significantly promoted the adipogenic, but not osteogenic, differentiation capacity of rat MSCs (Qin et al.). Notably, they also showed that knockout of NOS2 in MSCs resulted in significant obesity in rat fed a high-fat diet. Edited by: Atsushi Asakura, University of Minnesota Twin Cities, United States

Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies

Senescence in Mesenchymal Stem Cells: Functional Alterations, Molecular Mechanisms, and Rejuvenation Strategies.

Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies

Exploring Microenvironment Strategies to Delay Mesenchymal Stem Cell Senescence

A Mesenchymal stem cell Aging Framework, from Mechanisms to Strategies

Senescent Mesenchymal Stem/stromal Cells and Restoring Their Cellular Functions

The role of mitochondrial dysfunction in mesenchymal stem cell senescence

Application of mesenchymal stem cells for anti-senescence and clinical challenges

Editorial: Mesenchymal Stem Cell Senescence and Rejuvenation

Senescent Mesenchymal Stem Cells: Disease Mechanism and Treatment Strategy

Epigenetic Regulation in Mesenchymal Stem Cell Aging and Differentiation and Osteoporosis.

Suppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?

DEVELOPMENT PROGRESS OF MESENCHYMAL STEM CELLS SENESCENCE

Epigenetic Regulation in Mesenchymal Stem Cell Aging and Differentiation and Osteoporosis

Non-Coding RNAs Steering the Senescence-Related Progress, Properties, and Application of Mesenchymal Stem Cells

Metabolic Regulation of Mesenchymal Stem Cell in Expansion and Therapeutic Application

Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Senescence induces fundamental changes in the secretome of mesenchymal stromal cells (MSCs): implications for the therapeutic use of MSCs and their derivates

Mesenchymal stem cells: a revolution in therapeutic strategies of age-related diseases.

Rejuvenation of Mesenchymal Stem Cells to Ameliorate Skeletal Aging